$86.00
You’ll be briefly redirected to Link Money, our secure ACH payment partner, to connect your bank and complete payment.– Your bank login is never visible to or stored by us – Encrypted, bank-level security – A standard, trusted payment process
CJC 1295 with DAC is used in laboratory research to study prolonged GH releasing hormone activity, endocrine feedback loops, and hormone release dynamics. Researchers evaluate its role as a GH secretagogue and GHRH analog when examining sustained GH secretion, GH pulse patterns, and receptor signaling mechanisms.
The DAC component—also referred to as a drug affinity complex—allows the CJC 1295 DAC peptide to bind reversibly to serum albumin in research models. This DAC modification supports extended peptide exposure, fewer frequent injections, and reduced frequent dosing during experimental protocols, compared to shorter-acting mod GRF or modified GRF compounds.
No. While both are forms of CJC 1295, CJC 1295 w DAC is designed for prolonged activity, whereas non-DAC variants are studied for shorter-duration GH release. This distinction allows researchers to compare GH levels, IGF 1 levels, and natural GH pulses under different timing and exposure conditions.
In research settings, injection, subcutaneous injection, and dosing are terms commonly referenced when describing experimental delivery methods. However, Aion Aminos does not provide instructions, recommendations, or guidance for dosing, injection, or reconstitution. This CJC 1295 peptide therapy-related terminology appears strictly in an academic or experimental context and does not imply approved use.
